| Authors: |
Ma Y; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China; Center for Pharmacoeconomics and Outcome Research, China Pharmaceutical University, Nanjing, China., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA., Vanness DJ; Department of Health Policy and Administration, Pennsylvania State University, University Park, PA, USA., Li H; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China; Center for Pharmacoeconomics and Outcome Research, China Pharmaceutical University, Nanjing, China., Xie F; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; Center for Health Economics and Policy Analysis, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada. Electronic address: fengxie@mcmaster.ca. |